# Bluewillow Biologics Inc.

Canonical: https://abierto.us/vendors/bluewillow-biologics-inc-rl3uz5zdkft8

- UEI: RL3UZ5ZDKFT8
- CAGE: 3HT71
- Location: Ann Arbor, MI
- Awards in window: 1 (1 transactions), $0 obligated, November 22, 2024 to November 22, 2024

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N93019C00035 (definitive contract): $0, National Institutes of Health Niaid. Development of Nanovax TM (Oil in Water Nanoemulsion Adjuvant) Formulated Allergens as Intranasal Immunotherapeutic Vaccines for Peanut Allergy. Phase Ii.. https://www.usaspending.gov/award/CONT_AWD_75N93019C00035_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/bluewillow-biologics-inc-rl3uz5zdkft8.